ID

34383

Description

Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00806481

Link

https://clinicaltrials.gov/show/NCT00806481

Keywords

  1. 1/17/19 1/17/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 17, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Kidney Failure, Chronic NCT00806481

Eligibility Kidney Failure, Chronic NCT00806481

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic kidney disease patients aged 18 to 80 years
Description

ID.1

Data type

boolean

chronic kidney disease stage 3 (defined as a glomerular filtration rate of 30-60 ml/min/1.73m2)
Description

ID.2

Data type

boolean

office blood pressure controlled to less than 140/90 mmhg for 12 months before entry into the study
Description

ID.3

Data type

boolean

total cholesterol less than 5.5 mmol/l
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
existing or previous treatment within 1 year with a phosphate binder or vitamin d analogue
Description

ID.5

Data type

boolean

uncontrolled hyperphosphataemia (serum phosphate >1.8 mmol/l)
Description

ID.6

Data type

boolean

uncontrolled secondary hyperparathyroidism (pth >80 pg/ml)
Description

ID.7

Data type

boolean

diabetes mellitus
Description

ID.8

Data type

boolean

pregnancy
Description

ID.9

Data type

boolean

moderate-severe cardiac valvular disease
Description

ID.10

Data type

boolean

Similar models

Eligibility Kidney Failure, Chronic NCT00806481

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
chronic kidney disease patients aged 18 to 80 years
boolean
ID.2
Item
chronic kidney disease stage 3 (defined as a glomerular filtration rate of 30-60 ml/min/1.73m2)
boolean
ID.3
Item
office blood pressure controlled to less than 140/90 mmhg for 12 months before entry into the study
boolean
ID.4
Item
total cholesterol less than 5.5 mmol/l
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
existing or previous treatment within 1 year with a phosphate binder or vitamin d analogue
boolean
ID.6
Item
uncontrolled hyperphosphataemia (serum phosphate >1.8 mmol/l)
boolean
ID.7
Item
uncontrolled secondary hyperparathyroidism (pth >80 pg/ml)
boolean
ID.8
Item
diabetes mellitus
boolean
ID.9
Item
pregnancy
boolean
ID.10
Item
moderate-severe cardiac valvular disease
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial